Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors
DEKA Biosciences
DEKA Biosciences
Actuate Therapeutics Inc.
Eastern Cooperative Oncology Group
University Health Network, Toronto
Dana-Farber Cancer Institute
Children's Oncology Group
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)